EU green light for 13 new medicines in June
The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP)… read more.
The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP)… read more.
An international research team from the fields of veterinary medicine and genetics has developed a new survey tool to advance canine epilepsy diagnosis and research. Epilepsy and dyskinesia… read more.
Giving birth to a child after 40 is becoming more and more common – but it can entail an increased risk to the child, researchers say. A new… read more.
The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had… read more.
The European Medicines Agency (EMA) has launched a consultation on guidelines on how to include and retain pregnant and breastfeeding women in clinical trials. The goal is to… read more.
Regulator-approved AI models used in eye care vary widely in providing evidence for clinical performance and lack transparency about training data, including details of gender, age and ethnicity,… read more.
Valneva SE announced that the FDA and the U.S. Centers for Disease Control and Prevention (CDC), in a joint communication to the medical community, have recommended a pause… read more.
High-resolution computed tomography (HRCT) is the standard to diagnose and assess progression in interstitial lung disease (ILD), a key feature in systemic sclerosis (SSc). But AI-assisted interpretation has… read more.
Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat diabetes, appears to reduce monthly migraine days by more than half, researchers reported on June 20, 2025 at… read more.
In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system delves into the multifaceted implementation of pharmacogenomics—a rapidly evolving field that examines how… read more.
Women who work night shifts are more likely to suffer with moderate or severe asthma compared to women who work in the daytime, according to a study published… read more.
The most comprehensive analysis of rheumatoid arthritis data to date reveals that demographic changes and uneven health infrastructure have exacerbated the rheumatoid arthritis burden since 1980 and shows… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.